-
Comparison of Bispecific T-cell Engager Antibodies and CAR-T Therapies for Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
The DM77 and Rare Diseases: Analysis of Regional Legislation in Italy
Sep 9, 2025, 16:22 PM -
A Comparison of Methods for Missing Covariates in a Meta-Regression Using Data From a Systematic Review on Oral Epithelial Dysplasia
Sep 9, 2025, 16:22 PM -
The Incidence Mortality and Survival of Malignant Hematopoietic Neoplasms in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Experience of Pediatric Dental Screening in Hungary and in National Minority Groups in Romania
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Economic Evaluations of Medical Interventions for Adult People Living With Obesity: Protocol for a Systematic Literature Review
Sep 9, 2025, 16:22 PM -
NICE Has Embraced Single-Arm Trials in Technology Appraisals but Where Is the Guidance?
Sep 9, 2025, 16:22 PM -
Cost-Consequence Analysis of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Treatment vs. Large-Volume Paracentesis (LVP) in the Management of Refractory Ascites: Preliminary Results Overview From an Italian Healthcare Perspective
Sep 9, 2025, 16:22 PM -
Country-Related Differential Item Functioning in the EQ-5D-5L: Insights From the EuroQol Data Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)
Sep 9, 2025, 16:22 PM -
Economic Burden of Prostate Cancer Overall and by Stages Based on the French Real-World Nationwide Medico-Administrative Database (SNDS)
Sep 9, 2025, 16:22 PM -
ComboConnect—Bridging Access Gaps in Combination Therapies: An Italian Project in Collaboration With ISPOR Italy-Rome Chapter
Sep 9, 2025, 16:22 PM -
Integration of Germany’s AMNOG Framework With the Joint Clinical Assessment Process
Sep 9, 2025, 16:22 PM -
Wasfaty Improves Quality of Outpatient Pharmaceutical Service at a Tertiary Academic Hospital: A Descriptive Analysis
Sep 9, 2025, 16:22 PM -
Clinical and Economic Characteristics of eGFR-Mutated NSCLC Patients Treated With TKIs in South Korea: A Retrospective Cross-Sectional Analysis
Sep 9, 2025, 16:22 PM -
Evolution of National Price Negotiations for Pharmacy/Retail Medicines (Triparty Negotiations) in Sweden and Implications for Access
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Costs of Commercially Insured US Patients With Atopic Dermatitis Switching From First-Line to Second-Line Systemic Targeted Therapies
Sep 9, 2025, 16:22 PM -
Understanding the Impact of the NICE Severity Modifier: A Targeted Review of Oncology Submissions
Sep 9, 2025, 16:22 PM -
Real-World Evidence on the Broader Benefits of GLP-1RA-Based Therapies: A Global Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Price-Volume Regulation in France: Alignment Between Negotiated Thresholds With the French Economic Committee for Health Products (CEPS) and Real-World Observations
Sep 9, 2025, 16:22 PM